Tricida Directors Hit With Securities Suit Over Drug Approval

By Hailey Konnath · May 27, 2021, 6:45 PM EDT

A Tricida investor lodged a derivative suit against the pharmaceutical company's top brass Thursday, accusing them of hiding from investors that the company's new kidney disease drug was unlikely to garner...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Plaintiff(s) v. Defendant(s)

Case Number

1:99-mc-09999

Court

Delaware

Nature of Suit

Other Statutory Actions

Date Filed

January 01, 2026